NEIL BAKSH: Open Payments
NPI 1013434356 · LEBANON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,041 in 64 payments from 18 companies in 2025. Trend: 2023 $1,798 · 2024 $1,058 · 2025 $3,041
Food & beverage: $2,232Travel & lodging: $809
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $1,878 |
| Amgen Inc. | 11 | $155 |
| Baxter Healthcare | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $110 |
| SCPHARMACEUTICALS INC. | 2 | $86 |
| PFIZER INC. | 4 | $75 |
| CARDIVA MEDICAL, INC. | 3 | $69 |
| Abbott Laboratories | 3 | $66 |
Products named: FARAPULSE, REPATHA, ELIQUIS, Hillrom - Cardiac Ambulatory Monitor, LEQVIO, LifeVest, FUROSCIX, JARDIANCE.
Industry payments across PA — which companies pay providers there.
